Observational Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jan 15, 2024; 15(1): 81-91
Published online Jan 15, 2024. doi: 10.4239/wjd.v15.i1.81
Table 1 Clinical characteristics of type 1 diabetes with and without metabolic syndrome
Parameter
MS (-), n = 85
MS (+), n = 16
P value
Age (yr)30.87 ± 16.4431.50 ± 8.630.823
Duration11.04 ± 9.1712.96 ± 5.080.421
Male (%)38 (44.71)7 (43.75)0.944
Smoking (%)2 (2.35)0 (0)0.535
Drinking (%)3 (3.53)2 (12.50)0.129
Family history of Diabetes (presence) (%)17 (20.00)11 (68.75)< 0.001
Insulin regimen
Insulin pump1630.746
Basal-bolus insulin6613
Pre-mix insulin30
Insulin dose (IU/kg)0.86 ± 0.380.76 ± 0.270.775
Frequency of hypoglycemia (times/month)2.89 ± 3.241.43 ± 1.460.082
SBP (mmHg)120.92 ± 13.95130.50 ± 11.490.011
DBP (mmHg)79.45 ± 9.7787.00 ± 6.710.004
BMI (kg/m2)19.82 ± 2.5727.13 ± 4.07<0.001
Waist (cm)66.91 ± 7.2685.63 ± 10.42< 0.001
ZnT8 (+) (%)18 (21.18)0 (0)0.042
IA2 (+) (%)29 (34.12)3 (18.75)0.225
GAD (+) (%)37 (43.53)3 (18.75)0.063
TPOAb (+) (%)52 (61.18)2 (12.50)0.009
HDL (mmol/L)1.81 ± 0.481.29 ± 0.42< 0.001
LDL (mmol/L)2.69 ± 0.993.50 ± 0.900.003
TG (mmol/L)0.83 ± 0.461.85 ± 0.88< 0.001
CHOL (mmol/L)4.73 ± 1.155.44 ± 1.240.029
UA (μmol/L)317.72 ± 90.24417.63 ± 128.40< 0.001
FPG (mmol/L)8.35 ± 4.208.51 ± 5.290.894
HbA1c (%)7.34 ± 1.427.69 ± 1.910.388
eGDR8.42 ± 1.884.02 ± 0.87< 0.001
Table 2 Comparison of body composition parameters between women and men in type 2 diabetes with and without metabolic syndrome
Parameter
Men with MS (n = 7)
Men without MS (n = 38)
Women with MS (n = 9)
Women without MS (n = 47)
Fat mass (kg)20.50 ± 3.157.39 ± 3.2525.47 ± 9.2313.05 ± 4.24
bone mass (kg)3.91 ± 0.262.94 ± 0.572.87 ± 0.402.49 ± 0.34
Protein mass (kg)12.83 ± 1.019.05 ± 2.218.78 ± 1.587.32 ± 1.32
Water (kg)45.53 ± 3.6032.11 ± 7.8731.16 ± 5.5825.96 ± 4.65
Skeletal muscle mass (kg)41.64 ± 3.3029.38 ± 7.1928.53 ± 5.0923.74 ± 4.23
Fat-free mass (kg)62.27 ± 4.8844.12 ± 10.6442.82 ± 7.5435.78 ± 6.30
Body fat rate (%)24.66 ± 2.3814.06 ± 4.1336.13 ± 5.8326.26 ± 4.80
Visceral fat index10.14 ± 1.135.46 ± 1.8012.76 ± 2.868.13 ± 1.82
Trunk fat mass (kg)10.26 ± 1.613.71 ± 1.6112.76 ± 4.606.55 ± 2.13
Table 3 Correlation analysis between body composition parameters and clinical variables in type 1 diabetes

Visceral fat index
Trunk fat mass
Skeletal muscle mass

r
P value
r
P value
r
P value
Age0.1970.0480.2630.0080.2780.005
Duration0.2350.0180.2530.0110.0430.688
SBP0.1640.1050.2110.0360.395< 0.001
DBP0.1960.0520.2330.0200.369< 0.001
LDL0.374< 0.0010.352< 0.0010.1110.267
HDL-0.1030.305-0.1220.224-0.2290.021
TG0.342< 0.0010.344< 0.0010.1930.053
UA0.0080.9340.0320.7530.3320.001
HbA1c0.0440.6660.0560.579-0.0570.574
Insulin dose-0.0930.355-0.2440.014-0.3970.451
Table 4 Risk factors for metabolic syndrome, hypertension and dyslipidemia in binary logistic regression (forward conditional)
FactorsRegression coefficientStandard errorWaldP valueOR95%CI for OR
Lower
Upper
Metabolic syndromeeGDR-2.2190.9255.7480.0170.1090.0180.667
Visceral fat index1.2640.5824.7140.0303.5391.13111.077
Family history of Diabetes 1.4790.5088.4900.0044.3901.62311.874
HypertensioneGDR-0.7170.16618.534< 0.0010.4880.3520.677
Skeletal muscle mass0.1050.0358.9390.0031.1111.0371.190
DyslipidemiaTrunk fat mass0.1840.1023.2140.0731.2020.9831.469
eGDR-0.3460.1664.3320.0370.7080.5110.980